🔥🐔 BizChicken 🐔🔥
Companies Similar to Royalty Pharma plc
Sign Up Today!
Sign up for BizChicken and discover more about the corporations around you.
Regeneron Pharmaceuticals, Inc.
EYLEA, Dupixent, Libtayo, Praluent, REGEN-COV, Kevzara, Inmazeb
Regeneron Pharmaceuticals, Inc. discovers, develops, manufactures, and commercializes medicines for treating various diseases worldwide, including treatments like EYLEA, Dupixent, Libtayo, and more.
About | Leadership | About | History | About | About | Contact | Careers | Careers | Jobs | Jobs | Jobs | Careers | Culture | DEI | Careers | Leadership | Leadership | Leadership | Leadership | Leadership | Leadership | Leadership | Careers | Careers | Careers | Locations | Locations | Locations | Locations | Events | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Jobs | Jobs | Jobs | Jobs | Jobs | Site Map | Careers | About | About | About | About | Jobs | About | Leadership | Careers | Careers | About | Jobs | Jobs | Careers
Symbol: REGN
Recent Price: $702.59
Industry: Biotechnology
CEO: Dr. Leonard S. Schleifer M.D., Ph.D.
Sector: Healthcare
Employees: 14165
Address: 777 Old Saw Mill River Road, Tarrytown, NY 10591-6707
Phone: 914 847 7000
Leadership
- Leonard S. Schleifer, MD, PhD, Board co-Chair, President and Chief Executive Officer
- George D. Yancopoulos, MD, PhD, Board co-Chair, President and Chief Scientific Officer
- Zoran Berkovic, Senior Vice President, Financial Planning and Analysis
- Maya Bermingham, Senior Vice President, Public Policy and Government Affairs
- Leonard Brooks, Senior Vice President, Treasurer
- John Calabro, Senior Vice President, Internal Audit
- Christina Chan, Senior Vice President, Corporate Affairs
- Larry Coury, PhD, Senior Vice President, Associate General Counsel
- Ryan Crowe, Senior Vice President, Investor Relations & Strategic Analysis
- Matthew Everett, Senior Vice President, Global Procurement
- Chris Fenimore, Senior Vice President, Finance and Chief Financial Officer
- Rick Hall, Senior Vice President, Human Resources
- Justin Holko, Senior Vice President, Global Oncology/Hematology Commercial Business Unit
- Nouhad Husseini, Senior Vice President, Business Development
- Joseph J. LaRosa, Executive Vice President, General Counsel and Secretary
- Melissa Lozner, Senior Vice President, Chief Compliance Officer
- Marion McCourt, Executive Vice President, Commercial
- Bob McCowan, Senior Vice President, IT and Chief Information Officer
- Gonzalo Merino, PhD, Senior Vice President, Chief Intellectual Property Counsel and Associate General Counsel
- Richard O’Neal, Senior Vice President, Market Access
- Sally A. Paull, Executive Vice President, Human Resources
- Smita Pillai, Senior Vice President, Culture and DEI and Chief DEI Officer
- George Poth, Senior Vice President, Real Estate & Facilities Management
- Alessandra Ravetti, Senior Vice President, Associate General Counsel
- Kerry Reinertsen, PhD, Senior Vice President, Strategic Alliances
- David Snow, Senior Vice President, Global Head, Dupixent Franchise
- Mark Volpe, Senior Vice President, Tax
- Bola Akinlade, MD, FACP, Senior Vice President, Clinical Development, Immunology and Inflammation
- Hanne Bak, PhD, Senior Vice President, Preclinical Manufacturing and Process Development
- Aris Baras, MD, Senior Vice President, Regeneron Genetics Center®
- Ned Braunstein, MD, Executive Vice President, Regulatory Affairs and Global Patient Safety
- Gang Chen, PhD, Senior Vice President, Protein Expression Sciences
- Thomas DiCioccio, PhD, Senior Vice President, Pharmacometrics
- Benjamin Drosman, Senior Vice President, Global Development Quality & Regulatory Compliance
- Gregory Geba, MD, PhD, Senior Vice President, Global Development Scientific Council
- Philip Gregory, DPhil, Senior Vice President, Regeneron Cell Medicines
- Gary Herman, MD, Senior Vice President, Early Clinical Development and Experimental Sciences
- Boaz Hirshberg, MD, Senior Vice President, Clinical Sciences General Medicine
- Diana Hughes, MBBS, Senior Vice President, Global Patient Safety
- Bari Kowal, Senior Vice President, Development Operations and Portfolio Management
- Christos Kyratsous, PhD, Senior Vice President, Research
- Johnathan Lancaster, MD, PhD, Senior Vice President, Global Medical Affairs
- John Lin, MD, PhD, Senior Vice President, Immuno-Oncology and Head of Bispecifics
- Israel Lowy, MD, PhD, Senior Vice President, Translational and Clinical Sciences, Oncology
- Lynn Macdonald, PhD, Senior Vice President, Research
- Lori Morton, PhD, Senior Vice President, Research
- Andrew Murphy, PhD, Executive Vice President, Research
- Muriel O'Byrne, PhD, Senior Vice President, International Regulatory Affairs & Head, European Business Office
- William Olson, PhD, Senior Vice President, Therapeutic Proteins
- Mohammed Shameem, PhD, Senior Vice President, Formulations Development
- L. Andres Sirulnik, MD, PhD, Senior Vice President, Translational and Clinical Sciences, Hematology
- Randy Soltys, PhD, Senior Vice President, Drug Safety and Pharmacometrics
- Neil Stahl, PhD, Executive Vice President, Research and Development
- Robert Vitti, MD, Senior Vice President, Clinical Trial Excellence Strategy
- Brian Zambrowicz, PhD, Executive Vice President, Functional Genomics and Chief VelociGene® Operations
- Rajesh Ahuja, Senior Vice President, Fill/Finish and External Manufacturing
- Frederick Austin, Senior Vice President, Quality Control, Raheen
- Christine Childrose, Senior Vice President, Human Resources and HR Operations
- David Crenshaw, Senior Vice President, Associate General Counsel
- Tikiri Dissanayake, Senior Vice President, IOPS Technical Operations
- Patrice Gilooly, Senior Vice President, Quality Assurance and Operations
- Jennifer McNay, PhD, Senior Vice President, CMC Regulatory Sciences and Industrial Affairs
- Niall O’Leary, Senior Vice President and Site Head, IOPS Raheen
- Scott Oberman, Senior Vice President, Supply Chain Operations
- David Simon, Senior Vice President, IOPS Finance and Business Operations
- Daniel Van Plew, Executive Vice President and General Manager, Industrial Operations and Product Supply
- Benjamin Yocum, Senior Vice President, Manufacturing Operations
- James Wolfe, Senior Vice President, Process Sciences and Drug Product Engineering
- Bonnie L. Bassler, PhD, Director
- Michael S. Brown, MD, Director
- N. Anthony Coles, MD, Chair of the Board
- Joseph L. Goldstein, MD, Director
- Kathryn Guarini, PhD, Director
- Christine A. Poon, Lead Independent Director
- Arthur F. Ryan, Director
- Huda Y. Zoghbi, MD, Director
- Samantha Dickon, Director, Development Program Management
- Gervasio Batista, Sr. Scientist, Neuroscience
- James K. Gibson, Senior Regional Director, Immunology/Pulmonary
- Beth Brause, Director, Field Reimbursement Management
- Eric Prendergast, Director, Pricing Strategy
- Ashley Neff, Manager, Digital Communications
- Shari Loock, Associate Director, Sourcing
- Jennifer Davidson Hamilton, VP and Head of Precision Medicine
- Yi Zhang, Director, Health Economics & Outcomes Research
- Wilson Caldwell III, Director, GCO Vendor & Relationship Management
- David Stein, Director, Medical Operations
- Regeneron, Corporate
- Grant Anicete, Biotech Production Specialist I / IOPS Rensselaer
- Mary McKenna, Lead Quality Control Analyst / IOPS Raheen
- Ashley Lebby, Lead Senior Biotech Production Specialist / IOPS Rensselaer
- Varenka Rodriguez Diblasi, Principal Scientist, Bioinformatics
- Jessie Brown, Manager, Integrative Translational Genetics
- Gisu Eom, Lead Cloud DevOps Engineer
- Carmen Kenworthy, Scientist, Velocigene
- Ralph Hazlewood, Sr. Manager, Research Program Management
- Brandy Bennett, Sr. Director, R&D Strategy & Operations
Last updated: 2024-12-31
Reneo Pharmaceuticals, Inc.
REN001
Reneo Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, focuses on developing therapies for patients with rare genetic mitochondrial diseases. Its primary product, REN001, is a selective peroxisome proliferator-activated receptor delta agonist currently in clinical trials.
About | About | About | Management | Directors | Contact | Contact | Careers | Careers | About | About | About
Symbol: RPHM
Recent Price: $18.20
Industry: Biotechnology
CEO: Mr. Gregory J. Flesher
Sector: Healthcare
Employees: 8
Address: 18575 Jamboree Road, Irvine, CA 92612
Phone: 619 733 3852
Last updated: 2024-12-31
Royalty Pharma plc
biopharmaceutical royalties
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry, collaborating with various partners to acquire royalties on marketed and development-stage therapies in multiple therapeutic areas.
Contact | Contact | About | About | News | About | About | News | About | About | About | About
Symbol: RPRX
Recent Price: $25.32
Industry: Biotechnology
CEO: Mr. Pablo Gerardo Legorreta
Sector: Healthcare
Employees: 75
Address: 110 East 59th Street, New York, NY 10022
Phone: 212 883 0200
Last updated: 2024-12-31
Royalty Management Holding Corporation
N/A
Royalty Management Holding Corporation operates as a royalty company that identifies and invests in undervalued assets. It acquires and invests in natural resources, patents, intellectual property, and digital assets. The company was founded in 2021 and is based in Fishers, Indiana.
No tags available.
Symbol: RMCO
Recent Price: $1.01
Industry: Asset Management
CEO: Mr. Thomas M. Sauve
Sector: Financial Services
Employees: N/A
Address: 12115 Visionary Way, Fishers, IN 46038
Phone: (317) 855-9926
Last updated: 2024-12-31
Eli Lilly and Company
Pharmaceuticals
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide, specializing in treatments for diabetes, cancer, and other conditions.
Symbol: LLY
Recent Price: $773.84
Industry: Drug Manufacturers - General
CEO: Mr. David A. Ricks
Sector: Healthcare
Employees: 43000
Address: Lilly Corporate Center, Indianapolis, IN 46285
Phone: 317 276 2000
Last updated: 2024-12-31
Pfizer Inc.
biopharmaceutical products
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide, offering medicines and vaccines across various therapeutic areas.
About | About | About | About | About | About | About | About | About | About | DEI | ESG | About | Safety | About | ESG | About | About | About | About | About | About | About | About | About | About | History | About | About | About | About | About | About | News | About | Directors | Contact | Careers | Careers | Careers | Careers | Careers | Careers | DEI | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | About | About | About | About | About
Symbol: PFE
Recent Price: $26.42
Industry: Drug Manufacturers - General
CEO: Dr. Albert Bourla D.V.M., Ph.D.
Sector: Healthcare
Employees: 88000
Address: 235 East 42nd Street, New York, NY 10017
Phone: 212 733 2323
Last updated: 2024-12-31
BioCryst Pharmaceuticals, Inc.
ORLADEYO
Bio Cryst Pharmaceuticals, Inc. is a biotechnology company focused on discovering novel, oral, and small-molecule medicines, with marketed products including RAPIVAB and ORLADEYO, and a pipeline featuring BCX9930, BCX9250, and Galidesivir.
About | About | About | Contact | Careers | Careers | Safety | Jobs | Careers | About | About | About | About
Symbol: BCRX
Recent Price: $7.53
Industry: Biotechnology
CEO: Mr. Jon P. Stonehouse
Sector: Healthcare
Employees: 536
Address: 4505 Emperor Boulevard, Durham, NC 27703
Phone: 919 859 1302
Last updated: 2024-12-31
89bio, Inc.
pegozafermin
89bio, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for liver and cardio-metabolic diseases, primarily through its lead product candidate, pegozafermin, designed to treat nonalcoholic steatohepatitis and severe hypertriglyceridemia.
Symbol: ETNB
Recent Price: $7.87
Industry: Biotechnology
CEO: Mr. Rohan Palekar
Sector: Healthcare
Employees: 70
Address: 142 Sansome Street, San Francisco, CA 94104
Phone: 415 432 9270
Last updated: 2024-12-31
Coya Therapeutics, Inc.
COYA 101
Coya Therapeutics, Inc., a clinical-stage biotechnology company, develops proprietary medicinal products to modulate the function of regulatory T cells (Tregs), focusing on enhancing biologics and therapies for neurodegenerative and autoimmune diseases.
Symbol: COYA
Recent Price: $5.81
Industry: Biotechnology
CEO: Dr. Howard Berman Ph.D.
Sector: Healthcare
Employees: 8
Address: 5850 San Felipe Street, Houston, TX 77057
Phone: 800-587-8170
Last updated: 2024-12-31
Eloxx Pharmaceuticals, Inc.
ELX-02
Eloxx Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on developing ribosome modulation therapies for rare and ultra-rare premature stop codon diseases. The company's lead investigational drug, ELX-02, is in Phase 2 clinical trials for cystic fibrosis and nephropathic cystinosis.
Symbol: ELOX
Recent Price: $0.00
Industry: Biotechnology
CEO: Mr. Sumit Aggarwal M.B.A.
Sector: Healthcare
Employees: 18
Address: 480 Arsenal Way, Watertown, MA 02472
Phone: 781 577 5300
Last updated: 2024-12-31
Fortress Biotech, Inc.
Pharmaceutical and Biotechnology Products
Fortress Biotech, Inc., is a biopharmaceutical company focused on developing and commercializing a range of dermatology products and late-stage product candidates for various medical conditions.
About | About | About | Leadership | Directors | About | About | Contact | Careers | Careers | Careers | About | About | About
Symbol: FBIO
Recent Price: $2.18
Industry: Biotechnology
CEO: Dr. Lindsay Allan Rosenwald
Sector: Healthcare
Employees: 186
Address: 1111 Kane Concourse, Bay Harbor Islands, FL 33154
Phone: 781 652 4500
Leadership
- Lindsay A. Rosenwald, M.D., Chairman, President and Chief Executive Officer
- Michael S. Weiss, Executive Vice Chairman, Strategic Development
- David Jin, Chief Financial Officer and Head of Corporate Development
- George Avgerinos, Ph.D., Senior Vice President, Biologics Operations
- Samuel Berry, General Counsel and Corporate Secretary
- Jimmie Harvey, Jr., M.D., Director
- Malcolm Hoenlein, Director
- Dov Klein, Director
- J. Jay Lobell, Director
- Kevin L. Lorenz, J.D., Director
- Lucy Lu, M.D., Director
Last updated: 2024-12-31
Lumos Pharma, Inc.
LUM-201
Lumos Pharma, Inc., a clinical-stage biopharmaceutical company, develops and commercializes therapeutics for rare diseases, with its lead candidate LUM-201 in a Phase 2 trial for pediatric growth hormone deficiency.
Symbol: LUMO
Recent Price: $4.34
Industry: Biotechnology
CEO: Mr. Richard J. Hawkins
Sector: Healthcare
Employees: 33
Address: 4200 Marathon Boulevard, Austin, TX 78756
Phone: 512 215 2630
Last updated: 2024-12-31
Phio Pharmaceuticals Corp.
INTASYL therapeutic platform
Phio Pharmaceuticals Corp. develops immuno-oncology therapeutics using its INTASYL therapeutic platform to target tumor and immune cells by regulating genes of the immune system, focusing on products like PH-762, PH-894, and PH-804 for enhancing cancer immunotherapies in adoptive cell transfer.
Symbol: PHIO
Recent Price: $1.90
Industry: Biotechnology
CEO: Mr. Robert J. Bitterman
Sector: Healthcare
Employees: 8
Address: 257 Simarano Drive, Marlborough, MA 01752
Phone: 508 767 3861
Last updated: 2024-12-31
PTC Therapeutics, Inc.
Translarna, Emflaza, Tegsedi, Waylivra, Evrysdi
PTC Therapeutics, Inc. is a biopharmaceutical company dedicated to discovering, developing, and commercializing medicines for patients with rare disorders. The company offers a portfolio of products including treatments for Duchenne muscular dystrophy, rare diseases, and spinal muscular atrophy.
About | History | Leadership | About | Contact | Careers | Careers | Jobs | About | About | About | About
Symbol: PTCT
Recent Price: $45.77
Industry: Biotechnology
CEO: Dr. Matthew B. Klein F.A.C.S., M.D., M.S.
Sector: Healthcare
Employees: 988
Address: 100 Corporate Court, South Plainfield, NJ 07080
Phone: 908 222 7000
Leadership
- Matthew B. Klein, M.D., M.S., F.A.C.S., CEO, PTC Therapeutics, Inc.
- Neil Almstead, Ph.D., Chief Technical Operations Officer
- John Baird, Ph.D., Chief of Staff to the CEO
- Mark E. Boulding, Executive Vice President and Chief Legal Officer
- Lee Golden, M.D., Chief Medical Officer
- Pierre Gravier, Chief Financial Officer
- Mary Frances Harmon, Senior Vice President, Corporate and Patient Relations
- Linda Montella-Carter, Senior Vice President and Chief Information Officer
- Eric Pauwels, Chief Business Officer
- Hege Sollie-Zetlmayer, Chief Human Resources Officer
- Christine Utter, Senior Vice President, Chief Accounting Officer and Head of People Services
- Michael Schmertzler, Chairman
- William F. Bell, Jr., Managing Director and Head of Healthcare Services Practice, L.E.K. Consulting
- Allan Jacobson, Ph.D., University of Massachusetts Chan Medical School
- Stephanie S. Okey, M.S., Former SVP, Head of North America, Rare Disease – Genzyme
- Emma Reeve, Independent Board Director
- Mary Smith, The VENG Group
- David P. Southwell, Former CEO, TScan Therapeutics
- Glenn D. Steele, Jr., M.D., Ph.D., Chairman, GSteele Health Solutions
- Alethia Young, Chief Financial Officer, Bicycle Therapeutics
- Jerome B. Zeldis, M.D., Ph.D., Independent Board Director
Last updated: 2024-12-31
Rocket Pharmaceuticals, Inc.
Gene Therapies
Rocket Pharmaceuticals, Inc. is a biotechnology company focused on developing gene therapies for rare and devastating diseases, with multiple clinical-stage programs targeting disorders such as fanconi anemia, leukocyte adhesion deficiency-I, pyruvate kinase deficiency, and Danon disease.
Symbol: RCKT
Recent Price: $12.03
Industry: Biotechnology
CEO: Dr. Gaurav D. Shah M.D.
Sector: Healthcare
Employees: 268
Address: 9 Cedarbrook Drive, Cranbury, NJ 08512
Phone: 609 659 8001
Last updated: 2024-12-31
Repligen Corporation
bioprocessing technologies and systems
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing worldwide, offering products like Protein A ligands, chromatography columns, ELISA test kits, and filtration products.
About | About | Leadership | Locations | News | Sustainability | About | Events | Events | About | Events | Events | News | About | News | News | About | About | About | Contact | Contact | Contact | Contact | Contact | Contact | Contact | Locations | Contact | Contact | Contact | Contact | Contact | Contact | Careers | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | About | Jobs | Jobs | Jobs | Jobs | Careers | About | About | About | Careers | Contact | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Management | Careers | Careers | Careers | Careers | Careers | Careers | Culture | Careers | Careers | Careers | Careers | Careers | Leadership | Locations | News | Sustainability | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Management | Management | Management | Management | Management | Management | Management | Management | Culture | Culture | Culture | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Contact | Careers | Careers | Careers | Careers | Careers | Events | Events | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Events | Events | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Contact | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Contact | Contact | Contact | Locations | Contact | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Management | Jobs | Jobs | News | Careers | Careers | Careers | Careers | Contact | Contact | Contact | Contact | Contact | Careers | Careers | Careers | Careers | Contact | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Management | Careers | Careers | Careers | Careers | Careers | Careers | Culture | Careers | Careers | Careers | Careers | Careers | Leadership | Locations | News | Sustainability | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Management | Management | Management | Management | Management | Management | Management | Management | Culture | Culture | Culture | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Contact | Careers | Careers | Careers | Careers | Careers | Events | Events | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Events | Events | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Contact | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Contact | Contact | Contact | Locations | Contact | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Management | Jobs | Jobs | News | Careers | Careers | Careers | Careers | Contact | Contact | Contact | Contact | Contact | Careers | Careers | Careers | About | About
Symbol: RGEN
Recent Price: $143.81
Industry: Medical - Instruments & Supplies
CEO: Mr. Olivier Loeillot
Sector: Healthcare
Employees: 1783
Address: Building 1, Waltham, MA 02453
Phone: 781 250 0111
Leadership
- Mark A. Gambino, President and CEO
- Pradeep K. Gohil, Chief Financial Officer
- Matthew B. Wrobel, Chief Technology Officer
- Claudia A. Grunewald, Director of Quality Assurance
- Mickey R. Perry, Chief Operating Officer
- Paul C. Miller, General Counsel and Secretary
- James J. O'Brien, Chairman of the Board
- Diane Williams, Board Member
- Charles A. Jamieson, Board Member
- Rebecca D. Faulkner, Board Member
Last updated: 2024-12-31
Regulus Therapeutics Inc.
RG-012 and RGLS8429
Regulus Therapeutics Inc., based in San Diego, focuses on discovering and developing drugs targeting micro RNAs for treating various diseases.
Symbol: RGLS
Recent Price: $1.50
Industry: Biotechnology
CEO: Mr. Joseph P. Hagan M.B.A.
Sector: Healthcare
Employees: 30
Address: 4224 Campus Point Court, San Diego, CA 92121
Phone: 858 202 6300
Last updated: 2024-12-31
Rallybio Corporation
RLYB212
Rallybio Corporation is a clinical-stage biotechnology company focused on discovering, developing, manufacturing, and delivering therapies for severe and rare diseases, with a lead product candidate RLYB212 in clinical trials.
Contact | About | About | About | About | Careers | Careers | Careers | Careers | Careers | Careers | About | About
Symbol: RLYB
Recent Price: $0.93
Industry: Biotechnology
CEO: Dr. Stephen Uden M.B, M.D.
Sector: Healthcare
Employees: 25
Address: 234 Church Street, New Haven, CT 06510
Phone: 203 859 3820
Last updated: 2024-12-31
Scopus BioPharma Inc.
Duet Platform
Scopus Bio Pharma Inc., a clinical-stage biopharmaceutical company, focuses on developing transformational therapeutics for serious diseases with lead programs in immuno-oncology gene therapy.
Symbol: SCPS
Recent Price: $0.00
Industry: Biotechnology
CEO: Dr. Alan D. Horsager Ph.D.
Sector: Healthcare
Employees: 13
Address: 420 Lexington Avenue, New York, NY 10170
Phone: 212 479 2513
Last updated: 2024-12-31
XOMA Corporation
Pre-commercial therapeutic candidates
XOMA Corporation operates as a biotechnology royalty aggregator focusing on enhancing human health by acquiring potential future economics from pre-commercial therapeutic candidates licensed to pharmaceutical or biotech companies. With a portfolio of approximately 70 assets, it focuses on early to mid-stage clinical assets with commercial sales potential.
Symbol: XOMA
Recent Price: $26.09
Industry: Biotechnology
CEO: Mr. Owen P. Hughes Jr.
Sector: Healthcare
Employees: 13
Address: 2200 Powell Street, EmeryVille, CA 94608
Phone: 510 204 7200
Last updated: 2024-12-31